Most pfizer inc related news are at:
Pfizer Invites Public To View And Listen To Webcast Of January 31 Conference Call With Analysts 20 Dec 2011 | 07:00 pm
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10 a.m. EST on Tuesday, January 31, 201...
Pfizer Announces FDA Acceptance For Review Of New Drug Application For Tofacitinib For Adult Patients With Moderately To Severely Active Rheumatoid Ar... 20 Dec 2011 | 05:00 pm
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for tofacitinib (development c...
More pfizer inc related news:
Ever Wondered How Viagra Works? viagrasamples.com 16 Mar 2012 | 07:43 pm
Viagra was first introduced into the medical market to treat erectile dysfunction (also known as impotence) by pharmaceuticals company Pfizer Inc. in 1998. It is taken in tablet form, and those famous...
Pfizer Seeks US, Japan Approval for Lung Cancer Drug mesotheliomaweb.org 3 Jun 2011 | 01:57 am
Pharmaceutical manufacturer Pfizer, Inc., announced that it would seek approval for its new lung cancer drug crizotinib from both US and Japanese health authorities. The company submitted an applicati...
White & Case Obtains Significant Trial Victory for Pfizer whitecase.com 26 Jul 2012 | 11:00 pm
Global law firm White & Case LLP achieved a significant trial victory for Pfizer Inc. in a patent infringement case against seven generic drug companies regarding three patents covering the active ing...
Pfizer Reports Top-Line Results of EU Post-Authorization Safety and Efficacy Study of Lyrica’s Discontinuation Effects In Patients with Generalized An... pmpnews.com 23 Jul 2012 | 03:00 pm
NEW YORK--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) announced today that top-line results for Lyrica (pregabalin) capsules Study A0081147 Long Term Safety and Efficacy of Pregabalin in Subject...
Pfizer Invites Public To View And Listen To Webcast Of January 31 Conference Call With Analysts pfizer.com 20 Dec 2011 | 07:00 pm
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10 a.m. EST on Tuesday, January 31, 201...
Pfizer Announces FDA Acceptance For Review Of New Drug Application For Tofacitinib For Adult Patients With Moderately To Severely Active Rheumatoid Ar... pfizer.com 20 Dec 2011 | 05:00 pm
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for tofacitinib (development c...
Pfizer Reports Positive Results From Phase 3 Trial Of Lyrica (pregabalin) Capsules CV In Restless Legs Syndrome pfizer.com 16 Dec 2011 | 05:00 pm
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) announced today that a Phase 3 study for Lyrica (pregabalin) in patients with Restless Legs Syndrome (RLS) met each of its three co-primary endpoints...
Pfizer Reports Positive Results From Phase 3 Trial Of Lyrica (pregabaline) Capsules CV In Restless Legs Syndrome pfizer.com 16 Dec 2011 | 05:00 pm
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) announced today that a Phase 3 study for Lyrica (pregabalin) in patients with Restless Legs Syndrome (RLS) met each of its three co-primary endpoints...
Pfizer Reports Positive Results From Phase 3 Trial Of Lyrica (prebabalin) Capsules CV In Restless Legs Syndrome pfizer.com 16 Dec 2011 | 05:00 pm
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) announced today that a Phase 3 study for Lyrica (pregabalin) in patients with Restless Legs Syndrome (RLS) met each of its three co-primary endpoints...
Pfizer Broadens and Extends Commitment to Help Prevent Pneumococcal Disease in Infants and Young Children in the World’s Poorest Countries pfizer.com 16 Dec 2011 | 04:00 pm
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) today announced it has entered into a second supply agreement which will broaden and extend the duration of the Company’s commitment to help protect m...
